CN
CN
CN
1-22 of 197 result

News Mar 08, 2024

Join Our Founder and CEO @ DCAT Week

STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS

News Mar 02, 2024

Porton Pharma Solutions Joined the SBTi to Drive Climate Action

Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)

News Jan 05, 2024

Farewell to 2023, and WE are Sailing forward to 2024

Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)

News Sep 28, 2023

The Pharma Crystallization Summit (PCS) is held annually to bring together developers of new medicines with crystallization challenges and the crystallization experts (solution providers) in the industry and academia.

Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)

Porton Gets Improved in the 2023 S&P Global ESG Score

News Sep 20, 2023

Porton Gets Improved in the 2023 S&P Global ESG Score

Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)

News Sep 13, 2023

Porton Pharma Solutions Announces New Flagship Facility Offering Integrated API Crystallization and Drug Product Development Services

Porton announces the opening of a new drug development facility adjacent to its existing API synthesis facility in New Jersey, USA. (September 5, 2023 – CRANBURY, NJ)

News Aug 29, 2023

Pharma Digital Intelligence Summit will be held on 5th, September, 2023

Join us for a Journey of Innovation at J-STAR Research, Inc.'s Cranbury Open House!

News Aug 09, 2023

J-STAR Research, Inc.'s Cranbury Open House

Join us for a Journey of Innovation at J-STAR Research, Inc.'s Cranbury Open House!

[Important Notice] Porton Announcement Regarding the Change of Email Domain

News Jul 28, 2023

[Important Notice] Porton Announcement Regarding the Change of Email Domain

Porton Pharma Solutions Ltd. continues to expand its reach globally. Last year, we launched the construction of a new site in Menges, Slovenia. The state-of-the-art GMP manufacturing site will significantly expand Porton’s network beyond China and the US as it sets out to provide solutions to customers and partners in Europe.

Become part of Porton's community to access personalized insights and resources.
Subscribe to the Newsletter
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.

This website contains product information intended for different regions and may include details that are not available or authorized in your country. Please be aware that we assume no responsibility for any access to such information that may contravene applicable laws, regulations, or usage restrictions in your jurisdiction.

Become part of Porton's community to access personalized insights and resources.
Submit
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.
US: (609) 860-1300
CN: (86) 23-8608-3200